Pepstatin inhibition mechanism
- PMID: 339690
- DOI: 10.1007/978-1-4757-0719-9_12
Pepstatin inhibition mechanism
Abstract
Pepstatin is a low molecular weight, potent inhibitor specific for acid proteases with a Ki value of about 10(-10)M for pepsin. The chemical structure of pepstatin is essentially a hexapeptide which contains two residues of an unusual amino acid, 4-amino-3-hydroxy-6-methylheptanoic acid (statine). The complete structure of pepstatin is isovaleryl-L-valyl-L-valyl-statyl-L-alanyl-statine. To study its mode of inhibition, we prepared several derivatives and measured their kinetics of inhibition. Both N-acetyl-statine and N-acetyl-alanyl-statine are competitive inhibitors for pepsin with Ki values of 1.2 x 10(-4)M and 5.65 x 10(-6)M, respectively. The Ki value for N-acetyl-valyl-statine is 4.8 x 10(-6)M. These statyl derivatives, therefore, are very strong inhibitors. The Ki value for N-acetyl-statine is 600-fold smaller than that of its structural analog N-acetyl-leucine. The derivative which contains two statyl residues in a tetrapeptide exhibits inhibitory properties which approach those of pepstatin itself. Other acid proteases, human pepsin, human gastricsin, renin, cathepsin D, the acid protease from R. chinensis and bovine chymosin, also are inhibited by pepstatin and its derivatives. We suggest that the statyl residue is responsible for the unusual inhibitory capability of pepstatin and that statine is an analog of the previously proposed transition state for catalysis by pepsin and other acid proteases.
Similar articles
-
Mode of inhibition of acid proteases by pepstatin.J Biol Chem. 1976 Nov 25;251(22):7088-94. J Biol Chem. 1976. PMID: 993206
-
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.Biochemistry. 1985 Jun 18;24(13):3165-73. doi: 10.1021/bi00334a014. Biochemistry. 1985. PMID: 3927973
-
Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers.J Med Chem. 1979 May;22(5):577-9. doi: 10.1021/jm00191a023. J Med Chem. 1979. PMID: 379333
-
Biological activity of aspartic proteinase inhibitors related to pepstatin.Acta Biol Med Ger. 1981;40(10-11):1547-53. Acta Biol Med Ger. 1981. PMID: 6805191
-
Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.J Med Chem. 1980 Jan;23(1):27-33. doi: 10.1021/jm00175a006. J Med Chem. 1980. PMID: 6767029
Cited by
-
Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro).Sci Rep. 2024 Apr 18;14(1):8991. doi: 10.1038/s41598-024-59442-4. Sci Rep. 2024. PMID: 38637583 Free PMC article.
-
Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds.J Fungi (Basel). 2017 Aug 26;3(3):46. doi: 10.3390/jof3030046. J Fungi (Basel). 2017. PMID: 29371563 Free PMC article. Review.
-
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.Sci Rep. 2016 Dec 1;6:38027. doi: 10.1038/srep38027. Sci Rep. 2016. PMID: 27905556 Free PMC article.
-
A genomic survey of proteases in Aspergilli.BMC Genomics. 2014 Jun 25;15(1):523. doi: 10.1186/1471-2164-15-523. BMC Genomics. 2014. PMID: 24965873 Free PMC article.
-
Candida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic protease.PLoS One. 2012;7(2):e32513. doi: 10.1371/journal.pone.0032513. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384266 Free PMC article.